Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA). Nyxoah's flagship solution, Genio, uses hypoglossal nerve stimulation, an alternative to CPAP therapy. With Genio, Nyxoah offers a comfortable and elegant treatment alternative that allows patients suffering from obstructive sleep apnea to enjoy life to the fullest.
Major Shareholders
The chart illustrates Nyxoah’s major shareholders (on an undiluted basis), based on transparency notifications received, recordings in the company’s share register, and the current denominator. The chart does not take into account any "equivalent financial instruments" held by the major shareholders.